A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Clinical trial NCT07256912 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07256912
Sponsor: International Agency for Research on Cancer
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine Effectiveness HPV Vaccination Single Dose Immunogenicity Cervical Cancer Prevention Quadrivalent HPV Vaccine

Start date: 2026-04-01
Primary completion: 2028-12-01
Enrollment: 1266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.